Finally, the first new drug for sickle cell anemia in 20 years
In early July the Food and Drug Administration approved the first new drug for sickle cell patients in nearly 20 years. It was a watershed moment for people who suffer from the rare blood disorder that can cause debilitating pain. And for one physician it was the end of a 25-year journey. The drug, Endari, is made by Emmaus and has been approved for...